Gallstone
Conditions
Brief summary
Choledocholithiasis is reported to be present in 15-20% of patients with symptomatic gallstones. The single-stage management consists of performing either laparoscopic common bile duct exploration (LCBDE) or intraoperative endoscopic retrograde cholangiopancreatography (ERCP) at the same time as laparoscopic cholecystectomy (LC). Since the Coronavirus (COVID-19) pandemic, surgical practice has significantly been impacted. The pandemic has had ramifications on patient and staff safety, surgical techniques, minimally invasive procedures, theatre workflow, education and training. The investigators analysed a series of LCBDE procedures in our institution pre-, intra- and post-COVID-19 pandemic to assess the feasibility, efficacy and safety of this single-stage treatment approach following the pandemic.
Interventions
OTHERSingle-stage LC + LCBDE
Choledochotomy and transductal common bile duct exploration or transcystic choledochoscopy and common bile duct exploration
Sponsors
Imperial College London
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Inclusion criteria
* Patients that underwent single-stage LC + LCBDE for the management of choledocholithiasis with concomitant gallstones.
Exclusion criteria
* Patients that underwent LC only or LCBDE only
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Intraoperative measures | 90 days | Number of participants, size of choledochoscope used, rate of holmium laser lithotripsy use and stone clearance rates |
| Postoperative complications | 90 days | Number of participants, number of complications (e.g. bile leak and pancreatitis), duration of hospital length of stay |
Outcome results
None listed